News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
410,961 Results
Type
Article (47654)
Company Profile (82)
Press Release (363225)
Multimedia
Podcasts (24)
Webinars (10)
Section
Business (117345)
Career Advice (1333)
Deals (16258)
Drug Delivery (56)
Drug Development (50218)
Employer Resources (94)
FDA (7963)
Job Trends (9243)
News (191491)
Policy (14899)
Tag
Academia (2658)
Academic (1)
Accelerated approval (4)
Adcomms (7)
Allergies (48)
Alliances (33893)
ALS (66)
Alzheimer's disease (1173)
Antibody-drug conjugate (ADC) (79)
Approvals (8007)
Artificial intelligence (182)
Autoimmune disease (12)
Automation (8)
Bankruptcy (93)
Best Places to Work (7364)
BIOSECURE Act (10)
Biosimilars (32)
Biotechnology (53)
Bladder cancer (43)
Brain cancer (22)
Breast cancer (178)
Cancer (1611)
Cardiovascular disease (98)
Career advice (1115)
Career pathing (22)
CAR-T (107)
Cell therapy (281)
Cervical cancer (12)
Clinical research (39307)
Collaboration (656)
Compensation (73)
Complete response letters (6)
COVID-19 (1913)
CRISPR (32)
C-suite (153)
Cystic fibrosis (83)
Data (1593)
Decentralized trials (2)
Denatured (12)
Depression (29)
Diabetes (152)
Diagnostics (3916)
Digital health (12)
Diversity (4)
Diversity, equity & inclusion (24)
Drug discovery (95)
Drug pricing (51)
Drug shortages (6)
Duchenne muscular dystrophy (51)
Earnings (42884)
Editorial (23)
Employer branding (14)
Employer resources (82)
Events (50454)
Executive appointments (470)
FDA (8685)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (520)
Gene editing (67)
Generative AI (17)
Gene therapy (201)
GLP-1 (410)
Government (2379)
Grass and pollen (2)
Guidances (46)
Healthcare (11411)
Huntington's disease (10)
IgA nephropathy (11)
Immunology and inflammation (54)
Indications (20)
Infectious disease (2000)
Inflammatory bowel disease (90)
Inflation Reduction Act (4)
Influenza (39)
Intellectual property (63)
Interviews (264)
IPO (7804)
IRA (27)
Job creations (2180)
Job search strategy (962)
Kidney cancer (6)
Labor market (24)
Layoffs (255)
Leadership (9)
Legal (2583)
Liver cancer (37)
Lung cancer (223)
Lymphoma (112)
Machine learning (5)
Management (30)
Manufacturing (183)
MASH (49)
Medical device (6108)
Medtech (6110)
Mergers & acquisitions (8799)
Metabolic disorders (360)
Multiple sclerosis (53)
NASH (12)
Neurodegenerative disease (56)
Neuropsychiatric disorders (10)
Neuroscience (1543)
NextGen: Class of 2025 (3578)
Non-profit (4209)
Now hiring (24)
Obesity (162)
Opinion (145)
Ovarian cancer (62)
Pain (45)
Pancreatic cancer (52)
Parkinson's disease (109)
Partnered (18)
Patents (128)
Patient recruitment (73)
Peanut (27)
People (34651)
Pharmaceutical (23)
Pharmacy benefit managers (4)
Phase I (12416)
Phase II (16806)
Phase III (13161)
Pipeline (938)
Policy (80)
Postmarket research (1853)
Preclinical (6854)
Press Release (65)
Prostate cancer (72)
Psychedelics (20)
Radiopharmaceuticals (164)
Rare diseases (227)
Real estate (3804)
Recruiting (36)
Regulatory (11135)
Reports (28)
Research institute (2512)
Resumes & cover letters (189)
Rett syndrome (1)
RNA editing (1)
RSV (21)
Schizophrenia (55)
Series A (86)
Series B (44)
Service/supplier (10)
Sickle cell disease (37)
Special edition (13)
Spinal muscular atrophy (123)
Sponsored (22)
Startups (2269)
Stomach cancer (3)
Supply chain (29)
Tariffs (17)
The Weekly (12)
Vaccines (486)
Venture capitalists (16)
Weight loss (87)
Women's health (15)
Worklife (8)
Date
Last 7 days (526)
Last 30 days (1473)
Last 365 days (19720)
2025 (6441)
2024 (21220)
2023 (24577)
2022 (34288)
2021 (36293)
2020 (33462)
2019 (27934)
2018 (21089)
2017 (19470)
2016 (19442)
2015 (22909)
2014 (17246)
2013 (15241)
2012 (15213)
2011 (15869)
2010 (14709)
Location
Africa (568)
Alabama (44)
Alaska (3)
Arizona (89)
Arkansas (5)
Asia (25009)
Australia (4779)
California (3465)
Canada (1233)
China (322)
Colorado (145)
Connecticut (168)
Delaware (78)
Europe (59526)
Florida (566)
Georgia (122)
Idaho (26)
Illinois (301)
India (23)
Indiana (193)
Iowa (8)
Japan (131)
Kansas (50)
Kentucky (15)
Louisiana (4)
Maine (19)
Maryland (502)
Massachusetts (2538)
Michigan (140)
Minnesota (170)
Mississippi (1)
Missouri (50)
Montana (22)
Nebraska (14)
Nevada (27)
New Hampshire (29)
New Jersey (1141)
New Mexico (26)
New York (1156)
North Carolina (650)
North Dakota (5)
Northern California (1535)
Ohio (128)
Oklahoma (8)
Oregon (15)
Pennsylvania (733)
Puerto Rico (3)
Rhode Island (20)
South America (634)
South Carolina (12)
South Dakota (1)
Southern California (1331)
Tennessee (42)
Texas (543)
United States (13476)
Utah (93)
Virginia (109)
Washington D.C. (47)
Washington State (371)
West Virginia (1)
Wisconsin (33)
410,961 Results for "scleroderma research foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
The Scleroderma Research Foundation Appoints Dr. Gregory Gordon as Chief Medical Officer
The Scleroderma Research Foundation announces the appointment of Gregory Gordon, MD, JD as its first Chief Medical Officer.
January 25, 2024
·
5 min read
Biotech Bay
The Scleroderma Research Foundation Announces the Launch of the CONQUEST Trial Platform and IND Clearance
The Scleroderma Research Foundation, the nation’s largest non-profit funder of scleroderma research, announced that the FDA has cleared its Investigational New Drug application to launch the CONQUEST clinical trial platform and begin enrolling patients.
December 19, 2023
·
7 min read
Business
The Scleroderma Research Foundation (SRF) Announces Second Partnership for Conquest Trial Platform
The Scleroderma Research Foundation, the nation’s largest non-profit funder of scleroderma research, announced that Boehringer Ingelheim, a leading research-driven biopharmaceutical company, will contribute an experimental agent to CONQUEST, a highly innovative clinical trial platform created by the SRF.
October 3, 2023
·
4 min read
Press Releases
The Michael J. Fox Foundation Expands Landmark Parkinson’s Research Study toward Better Treatments and Prevention
April 30, 2025
·
10 min read
Press Releases
Lung Cancer Research Foundation Announces Research Collaboration with Israel Cancer Research Fund
February 19, 2025
·
5 min read
Press Releases
Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration
March 18, 2025
·
3 min read
Press Releases
Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma
April 7, 2025
·
6 min read
Press Releases
Final Call for Biocodex Microbiota Foundation $50,000 2025 USA Microbiome Research Grant
April 2, 2025
·
2 min read
Press Releases
Lung Cancer Research Foundation Announces 2025 Requests for Proposals
January 8, 2025
·
4 min read
Layoffs
Entrada Cuts 20% of Workforce, Targeting Research Employees
Entrada is paring back its research staff even as it gears up to hire employees to support a planned clinical trial for a Duchenne muscular dystrophy candidate.
April 30, 2025
·
1 min read
·
Angela Gabriel
1 of 41,097
Next
